RANI - Rani Therapeutics Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RANI is currently covered by 2 analysts with an average price target of $8. This is a potential upside of $7.43 (875.61%) from yesterday's end of day stock price of $0.82.

Rani Therapeutics Holdings's activity chart (see below) currently has 27 price targets and 42 ratings on display. The stock rating distribution of RANI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.15% with an average time for these price targets to be met of 43.22 days.

Highest price target for RANI is $11, Lowest price target is $5, average price target is $8.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 01-Apr-2026. First documented stock forecast 24-Aug-2021.

Currently out of the existing stock ratings of RANI, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Mar-2024

$5

$3.92 (362.96%)

5 months 15 days ago
(01-Apr-2026)

0/2 (0%)

$4.19 (517.28%)

Buy Since 24-Aug-2021

$11

$9.92 (918.52%)

5 months 20 days ago
(27-Mar-2026)

1/3 (33.33%)

$10.19 (1258.02%)

65

Buy Since 13-Jun-2022

$4

1 years 4 months ago
(16-May-2025)

0/2 (0%)

$3.43 (601.75%)

Buy Since 27-Jul-2022

$9

1 years 5 months 13 days ago
(03-Apr-2025)

0/10 (0%)

$6.94 (336.89%)

Buy Since 24-Aug-2021

$8

$6.92 (640.74%)

$8

1 years 5 months 15 days ago
(01-Apr-2025)

1/4 (25%)

$6.77 (550.41%)

65

Show more analysts

Please expand the browser size to see the chart

What is RANI (Rani Therapeutics Holdings) average time for price targets to be met?

On average it took 43 days for the stock forecasts to be reached, with an average price target met ratio of 23.15%.

Which analyst most recently updated their price target on RANI (Rani Therapeutics Holdings)?

Edward Nash

Which analyst has the current lower performing score on RANI (Rani Therapeutics Holdings) with a proven track record?

ROBERT HAZLETT

Which analyst has the most public recommendations on RANI (Rani Therapeutics Holdings)?

Edward Nash works at CANACCORD and has 10 price targets and 8 ratings on RANI

Which analyst is the currently most bullish on RANI (Rani Therapeutics Holdings)?

Geoff Meacham with the highest potential upside of $15.87

Which analyst is the currently most reserved on RANI (Rani Therapeutics Holdings)?

Mitchell Kapoor with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?